Rufinamide Suspension
Product Images NDC 69452-223

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Rufinamide (NDC 69452-223). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Figureav2)

Illustration showing components of Rufinamide oral suspension packaging including the bottle, box, bottle adapter, and two oral syringes for measuring and administering the suspension.*

FDA Label Image

Figure B (Figureb)

Illustration showing a hand holding a bottle of Rufinamide oral suspension with arrows and text indicating to shake the bottle well before use.*

FDA Label Image

Figure C (Figurec)

An instructional diagram showing a bottle adapter piece. The image depicts the adapter's ridged design for secure attachment to a bottle, labeled clearly as 'bottle adapter.'*

FDA Label Image

Figure D (Figured)

Illustration showing a hand holding a bottle of Rufinamide oral suspension, with an arrow indicating the action of opening the bottle cap. This diagram likely demonstrates how to open the medication bottle properly.*

FDA Label Image

Figure E (Figureev2)

An instructional illustration showing a blue oral syringe with volume markings from 1 mL to 20 mL, labeled in milliliters. The plunger of the syringe is indicated with a label pointing to it. A magnified view highlights volume increments between 14 to 20 mL for clearer reading.*

FDA Label Image

Figure F (Figurefv2)

An instructional illustration showing a hand holding a blue oral syringe above a bottle opening. The syringe has a volume scale marked in milliliters (mL), and a downward arrow indicates the syringe should be inserted into the bottle for drawing the liquid medication.*

FDA Label Image

Figure G (Figuregv2)

An instructional illustration showing a hand holding an oral syringe filled to the 20 mL mark, being filled from a medicine bottle or container with a spout. An arrow pointing downward indicates the direction to dispense or draw the liquid. The syringe is graduated in milliliters from 0 to 20 mL for measurement.*

FDA Label Image

Figure H (Figurehv2)

An instructional illustration showing hands measuring liquid in a syringe. The syringe is filled with blue liquid marked with volume gradations from 0 to 10 mL. Text indicates to measure to the end of the plunger. The image demonstrates correct liquid measurement technique using the syringe.*

FDA Label Image

Figure I (Figureiv2)

An instructional illustration showing a person receiving an oral suspension dose from a syringe. The syringe is marked with volume measurements up to 15 mL and is being gently placed into the patient's mouth for oral administration.*

FDA Label Image

Figure J (Figurejv2)

An instructional illustration showing the use of a dosing syringe for Rufinamide oral suspension 40 mg/mL. The first panel depicts a hand pulling the syringe plunger upward while the syringe tip is immersed in a liquid-filled cup. The second panel shows a hand pressing the plunger down, dispensing the liquid from the syringe.*

FDA Label Image

Figure K (Figurek)

An instructional line drawing showing a hand gripping and opening a bottle cap. The illustration demonstrates how to open a sealed bottle, likely related to a liquid medication container such as an oral suspension.*

FDA Label Image

Image001

Packaging label for Rufinamide Oral Suspension 40 mg/mL by Bionpharma Inc. The label indicates it is for oral administration only, supplied with two 20 mL oral syringes, and comes in a 460 mL bottle. The label includes storage instructions, dosage, and pharmacist dispensing information, with the NDC 69452-223-84 visible.*

FDA Label Image

Structure (Structure)

Chemical structure of Rufinamide, the active ingredient in the product Rufinamide oral suspension 40 mg/mL by Bionpharma Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.